List of works - Michelle M Mielke

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

scientific article

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

scientific article published on 08 January 2014

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

scientific article

High total cholesterol levels in late life associated with a reduced risk of dementia.

scientific article published in May 2005

Brain β-amyloid load approaches a plateau

scientific article published on 27 February 2013

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

scientific article

Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging

scientific article published on 18 December 2012

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

scientific article published on May 2015

Vascular factors predict rate of progression in Alzheimer disease

scientific article published in November 2007

Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding.

scientific article published in September 2000

Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease

scientific article published on 05 February 2009

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

scientific article

Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program

scientific article published on 19 August 2009

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

scientific article published on 30 September 2016

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

scientific article published on December 18, 2013

Mild cognitive impairment due to Alzheimer disease in the community

scientific article published on August 2013

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study

scientific article

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

scientific article published on 16 October 2013

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies

scientific article

Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency.

scientific article published in March 1998

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

scientific article

Brain injury biomarkers are not dependent on β-amyloid in normal elderly

scientific article published on 19 February 2013

Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study

scientific article

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

scientific article

Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease

scientific article published in January 2012

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

scientific article published on January 1, 2016

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

scientific article

Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

scientific article

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

scientific article published on 18 November 2016

Adiposity indicators and dementia over 32 years in Sweden.

scientific article

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

scientific article

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings

scientific article

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study

scientific article published on 26 April 2017

Association of type 2 diabetes with brain atrophy and cognitive impairment

scientific article published on 19 March 2014

Indicators of amyloid burden in a population-based study of cognitively normal elderly

scientific article published on 12 September 2012

The 32-year relationship between cholesterol and dementia from midlife to late life

scientific article

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

scientific article

Serum sphingomyelins and ceramides are early predictors of memory impairment

scientific article published on 05 May 2008

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

scientific article

Association of lifetime intellectual enrichment with cognitive decline in the older population

scientific article

Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

scientific article

Developing novel blood-based biomarkers for Alzheimer's disease

scientific article

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study

scientific article

Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation

scientific article

Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study

scientific article published on 17 November 2015

Recent advances in the application of metabolomics to Alzheimer's Disease

scientific article published on June 29, 2013

Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease

scientific article published on January 2011

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

scientific article

Current state of Alzheimer's fluid biomarkers

scholarly article by José Luis Molinuevo et al published 1 December 2018 in Acta Neuropathologica

Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.

scientific article

List of works by Michelle M Mielke

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study

High total cholesterol levels in late life associated with a reduced risk of dementia.

Brain β-amyloid load approaches a plateau

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

Vascular factors predict rate of progression in Alzheimer disease

Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding.

Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

Evidence for neurocognitive plasticity in at-risk older adults: the experience corps program

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

Mild cognitive impairment due to Alzheimer disease in the community

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies

Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency.

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly

Brain injury biomarkers are not dependent on β-amyloid in normal elderly

Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study

The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

Adiposity indicators and dementia over 32 years in Sweden.

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study

Association of type 2 diabetes with brain atrophy and cognitive impairment

Indicators of amyloid burden in a population-based study of cognitively normal elderly

The 32-year relationship between cholesterol and dementia from midlife to late life

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

Serum sphingomyelins and ceramides are early predictors of memory impairment

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

Association of lifetime intellectual enrichment with cognitive decline in the older population

Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Developing novel blood-based biomarkers for Alzheimer's disease

Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study

Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation

Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study

Recent advances in the application of metabolomics to Alzheimer's Disease

Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease

Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease

Current state of Alzheimer's fluid biomarkers

Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction.